826 records found.
Jan 20, 2020
Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody
Jan 14, 2020
New Head-to-Head Phase 3 Data Show SKYRIZI(TM) (risankizumab) Superior to Cosentyx® (secukinumab) Across Primary and All Ranked Secondary Endpoints in Adults with Moderate to Severe Plaque Psoriasis at 52 Weeks
Jan 13, 2020
John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma
Jan 10, 2020
Regeneron to Report Fourth Quarter and Full Year 2019 Financial and Operating Results and Host Conference Call and Webcast on February 6, 2020
Jan 09, 2020
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
Jan 09, 2020
Integral Molecular Announces Preclinical P2X7 Antibody Assets for Autoimmune Disorders
Jan 08, 2020
Revitope Oncology Appoints Steve Arkinstall, D.Phil., as Chief Executive Officer
Jan 08, 2020
Agenus Commences Phase 1 trial with AGEN1223
Jan 08, 2020
Publication Highlights Regeneron's Costimulatory Bispecific Antibodies, an Emerging Class of Cancer Immunotherapy
Jan 07, 2020
Avidity Biosciences Announces Presentation at the 38th Annual J.P. Morgan Healthcare Conference
Dec 23, 2019
Global Therapeutic Proteins Market Report 2020: Market was Valued at $93.14 Billion in 2018 and is Expected to Grow to $172.87 Billion through 2022 - ResearchAndMarkets.com
Dec 19, 2019
Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody
Dec 19, 2019
Greater Flexibility in Clinical Trial Design Needed for Lupus
Dec 18, 2019
BioInvent Has Entered Into a Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1206 in Combination With KEYTRUDA® in Advanced Solid Tumors
Dec 18, 2019
Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality® (galcanezumab-gnlm)
Dec 18, 2019
Kleo Pharmaceuticals to Present at Biotech Showcase 2020
Dec 18, 2019
Amgen/Novartis' Aimovig Label Revision and Teva's Ajovy Autoinjector Delay Clear the Way for Continued Growth of Eli Lilly's Emgality in the US Migraine Prevention Market, According to Spherix Global Insights
Dec 18, 2019
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
Dec 18, 2019
AbbVie Receives European Commission Approval of RINVOQ(TM) (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
Dec 17, 2019
The Biosimilars Market in the US: 2019 Payer Insights Report Featuring 47 Insights Supported by 199 Directly Quoted Comments from Industry Experts

Pages